Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Sep;85(7):1055–1063. doi: 10.1054/bjoc.2001.2038

Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists

R P Coppes 1, L J W Zeilstra 1, H H Kampinga 1, A W T Konings 1
PMCID: PMC2375094  PMID: 11592779

Abstract

Damage to salivary glands after radiotherapeutic treatment of head and neck tumours can severely impair the quality of life of the patients. In the current study we have investigated the early-to-late pathogenesis of the parotid gland after radiation. Also the ability to ameliorate the damage using pretreatment with adrenergic or muscarinic receptor agonists is studied. Rats were locally irradiated with or without i.p. pretreatment with phenylephrine (α-adrenoceptor agonist, 5 mg kg−1), isoproterenol (β-adrenoceptor agonist, 5 mg kg−1), pilocarpine (4 mg kg−1), methacholine (3.75 mg kg−1) (muscarinic receptor agonists) or methacholine plus phenylephrine. Parotid salivary flow rate, amylase secretion, the number of cells and gland histology were monitored sequentially up to 240 days postirradiation. The effects were described in 4 distinct phases. The first phase (0–10 days) was characterised by a rapid decline in flow rate without changes in amylase secretion or acinar cell number. The second phase (10–60 days) consists of a decrease in amylase secretion and is paralleled by acinar cell loss. Flow rate, amylase secretion and acinar cell numbers do not change in the third phase (60–120 days). The fourth phase (120–240 days) is determined by a further deterioration of gland function but an increase in acinar cell number, albeit with poor tissue morphology. All drug pretreatments used could reduce radiation effects in phase I and II. The protective effects were lost during phase IV, with the exception of methacholine plus phenylephrine pretreatment. The latter combination of drugs ameliorated radiation-damage throughout the entire follow-up time. The data show that combined pre-irradiation stimulation of muscarinic acetylcholine receptors with methacholine plus α-adrenoceptors with phenylephrine can reduce both early and late damage, possibly involving the PLC/PIP2 second messenger pathways. This opens perspectives for the development of clinical applicable methods for long-term sparing of parotid glands subjected to radiotherapy of head and neck cancer patients. © 2001 Cancer Research Campaignhttp://www.bjcancer.com

Keywords: head and neck cancer, irradiation, prophylactic treatment, parotid gland

Full Text

The Full Text of this article is available as a PDF (197.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burford-Mason A. P., Cummins M. M., Brown D. H., MacKay A. J., Dardick I. Immunohistochemical analysis of the proliferative capacity of duct and acinar cells during ligation-induced atrophy and subsequent regeneration of rat parotid gland. J Oral Pathol Med. 1993 Nov;22(10):440–446. doi: 10.1111/j.1600-0714.1993.tb00122.x. [DOI] [PubMed] [Google Scholar]
  2. Chuang T. T., Iacovelli L., Sallese M., De Blasi A. G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharmacol Sci. 1996 Nov;17(11):416–421. doi: 10.1016/s0165-6147(96)10048-1. [DOI] [PubMed] [Google Scholar]
  3. Coppes R. P., Vissink A., Zeilstra L. J., Konings A. W. Muscarinic receptor stimulation increases tolerance of rat salivary gland function to radiation damage. Int J Radiat Biol. 1997 Nov;72(5):615–625. doi: 10.1080/095530097143112. [DOI] [PubMed] [Google Scholar]
  4. Coppes R. P., Zeilstra L. J., Vissink A., Konings A. W. Sialogogue-related radioprotection of salivary gland function: the degranulation concept revisited. Radiat Res. 1997 Sep;148(3):240–247. [PubMed] [Google Scholar]
  5. Dardick I. Mounting evidence against current histogenetic concepts for salivary gland tumorigenesis. Eur J Morphol. 1998 Aug;36 (Suppl):257–261. [PubMed] [Google Scholar]
  6. Denny P. C., Ball W. D., Redman R. S. Salivary glands: a paradigm for diversity of gland development. Crit Rev Oral Biol Med. 1997;8(1):51–75. doi: 10.1177/10454411970080010301. [DOI] [PubMed] [Google Scholar]
  7. Eisbruch A., Ten Haken R. K., Kim H. M., Marsh L. H., Ship J. A. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):577–587. doi: 10.1016/s0360-3016(99)00247-3. [DOI] [PubMed] [Google Scholar]
  8. El-Mofty S. K., Kahn A. J. Early membrane injury in lethally irradiated salivary gland cells. Int J Radiat Biol Relat Stud Phys Chem Med. 1981 Jan;39(1):55–62. doi: 10.1080/09553008114550071. [DOI] [PubMed] [Google Scholar]
  9. Fleming N., Mellow L., Bhullar D. Regulation of the cAMP signal transduction pathway by protein kinase C in rat submandibular cells. Pflugers Arch. 1992 May;421(1):82–89. doi: 10.1007/BF00374737. [DOI] [PubMed] [Google Scholar]
  10. Franzén L., Funegård U., Sundström S., Gustafsson H., Danielsson A., Henriksson R. Fractionated irradiation and early changes in salivary glands. Different effects on potassium efflux, exocytotic amylase release and gland morphology. Lab Invest. 1991 Feb;64(2):279–283. [PubMed] [Google Scholar]
  11. Funegård U., Johansson I., Franzén L., Ericson T., Nyström H., Henriksson R. Rat salivary gland function after fractionated irradiation. Acta Oncol. 1997;36(2):191–198. doi: 10.3109/02841869709109229. [DOI] [PubMed] [Google Scholar]
  12. Gerstin E. H., Jr, Ehlert F. J. Inhibition of muscarinic stimulated phosphoinositide hydrolysis in the rat parotid gland by cAMP. Life Sci. 1996;58(2):145–153. doi: 10.1016/0024-3205(95)02267-8. [DOI] [PubMed] [Google Scholar]
  13. Gomperts B. D. GE: a GTP-binding protein mediating exocytosis. Annu Rev Physiol. 1990;52:591–606. doi: 10.1146/annurev.ph.52.030190.003111. [DOI] [PubMed] [Google Scholar]
  14. Gustafsson H., Franzén L., Sundström S., Henriksson R. Different effects of fractionated irradiation on potassium efflux and exocytotic amylase release. Acta Otolaryngol Suppl. 1992;492:94–98. doi: 10.3109/00016489209136820. [DOI] [PubMed] [Google Scholar]
  15. Henriksson R., Fröjd O., Gustafsson H., Johansson S., Yi-Qing C., Franzén L., Bjermer L. Increase in mast cells and hyaluronic acid correlates to radiation-induced damage and loss of serous acinar cells in salivary glands: the parotid and submandibular glands differ in radiation sensitivity. Br J Cancer. 1994 Feb;69(2):320–326. doi: 10.1038/bjc.1994.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jensen A. B., Hansen O., Jørgensen K., Bastholt L. Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncol. 1994;33(5):487–491. doi: 10.3109/02841869409083923. [DOI] [PubMed] [Google Scholar]
  17. Johnson J. T., Ferretti G. A., Nethery W. J., Valdez I. H., Fox P. C., Ng D., Muscoplat C. C., Gallagher S. C. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med. 1993 Aug 5;329(6):390–395. doi: 10.1056/NEJM199308053290603. [DOI] [PubMed] [Google Scholar]
  18. LeVeque F. G., Montgomery M., Potter D., Zimmer M. B., Rieke J. W., Steiger B. W., Gallagher S. C., Muscoplat C. C. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol. 1993 Jun;11(6):1124–1131. doi: 10.1200/JCO.1993.11.6.1124. [DOI] [PubMed] [Google Scholar]
  19. Leslie M. D., Dische S. The early changes in salivary gland function during and after radiotherapy given for head and neck cancer. Radiother Oncol. 1994 Jan;30(1):26–32. doi: 10.1016/0167-8140(94)90006-x. [DOI] [PubMed] [Google Scholar]
  20. Martinez J. R., Zhang G. H. Cross-talk in signal transduction pathways of rat submandibular acinar cells. Eur J Morphol. 1998 Aug;36 (Suppl):190–193. [PubMed] [Google Scholar]
  21. Nagler R. M., Baum B. J., Fox P. C. Acute effects of X irradiation on the function of rat salivary glands. Radiat Res. 1993 Oct;136(1):42–47. [PubMed] [Google Scholar]
  22. Nagler R. M., Baum B. J., Miller G., Fox P. C. Long-term salivary effects of single-dose head and neck irradiation in the rat. Arch Oral Biol. 1998 Apr;43(4):297–303. doi: 10.1016/s0003-9969(97)00120-9. [DOI] [PubMed] [Google Scholar]
  23. Paardekooper G. M., Cammelli S., Zeilstra L. J., Coppes R. P., Konings A. W. Radiation-induced apoptosis in relation to acute impairment of rat salivary gland function. Int J Radiat Biol. 1998 Jun;73(6):641–648. doi: 10.1080/095530098141898. [DOI] [PubMed] [Google Scholar]
  24. Peter B., Van Waarde M. A., Vissink A., 's-Gravenmade E. J., Konings A. W. Radiation-induced cell proliferation in the parotid and submandibular glands of the rat. Radiat Res. 1994 Nov;140(2):257–265. [PubMed] [Google Scholar]
  25. Peter B., Van Waarde M. A., Vissink A., s-Gravenmade E. J., Konings A. W. The role of secretory granules in radiation-induced dysfunction of rat salivary glands. Radiat Res. 1995 Feb;141(2):176–182. [PubMed] [Google Scholar]
  26. Peter B., Van Waarde M. A., Vissink A., s-Gravenmade E. J., Konings A. W. The role of secretory granules in the radiosensitivity of rat salivary gland acini--a morphological study. Radiat Res. 1994 Dec;140(3):419–428. [PubMed] [Google Scholar]
  27. Phillips R. M. X-ray-induced changes in function and structure of the rat parotid gland. J Oral Surg. 1970 Jun;28(6):432–437. [PubMed] [Google Scholar]
  28. Redman R. S. Proliferative activity by cell type in the developing rat parotid gland. Anat Rec. 1995 Apr;241(4):529–540. doi: 10.1002/ar.1092410411. [DOI] [PubMed] [Google Scholar]
  29. Roesink J. M., Konings A. W., Terhaard C. H., Battermann J. J., Kampinga H. H., Coppes R. P. Preservation of the rat parotid gland function after radiation by prophylactic pilocarpine treatment: radiation dose dependency and compensatory mechanisms. Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):483–489. doi: 10.1016/s0360-3016(99)00185-6. [DOI] [PubMed] [Google Scholar]
  30. Sawaki K., Baum B. J., Ambudkar I. S. Alpha 1-adrenergic and m3-muscarinic receptor stimulation of phosphatidylinositol 4,5-bisphosphate-specific phospholipase C are independently mediated by G alpha q/11 in rat parotid gland membranes. Arch Biochem Biophys. 1995 Jan 10;316(1):535–540. doi: 10.1006/abbi.1995.1071. [DOI] [PubMed] [Google Scholar]
  31. Shannon I. L., Trodahl J. N., Starcke E. N. Radiosensitivity of the human parotid gland. Proc Soc Exp Biol Med. 1978 Jan;157(1):50–53. doi: 10.3181/00379727-157-39988. [DOI] [PubMed] [Google Scholar]
  32. Sodicoff M., Pratt N. E., Sholley M. M. Ultrastructural radiation injury of rat parotid gland: a histopathologic dose-response study. Radiat Res. 1974 May;58(2):196–208. [PubMed] [Google Scholar]
  33. Valdez I. H., Atkinson J. C., Ship J. A., Fox P. C. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry. Int J Radiat Oncol Biol Phys. 1993 Jan;25(1):41–47. doi: 10.1016/0360-3016(93)90143-j. [DOI] [PubMed] [Google Scholar]
  34. Valdez I. H., Wolff A., Atkinson J. C., Macynski A. A., Fox P. C. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer. 1993 Mar 1;71(5):1848–1851. doi: 10.1002/1097-0142(19930301)71:5<1848::aid-cncr2820710522>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  35. Vissink A., 's-Gravenmade E. J., Ligeon E. E., Konings W. T. A functional and chemical study of radiation effects on rat parotid and submandibular/sublingual glands. Radiat Res. 1990 Dec;124(3):259–265. [PubMed] [Google Scholar]
  36. Vissink A., Down J. D., Konings A. W. Contrasting dose-rate effects of gamma-irradiation on rat salivary gland function. Int J Radiat Biol. 1992 Feb;61(2):275–282. doi: 10.1080/09553009214550911. [DOI] [PubMed] [Google Scholar]
  37. Vissink A., Gravenmade E. J., Konings A. W., Ligeon E. E. An adaptation of the Lashley cup for use in rat saliva collection. Arch Oral Biol. 1989;34(7):577–578. doi: 10.1016/0003-9969(89)90097-6. [DOI] [PubMed] [Google Scholar]
  38. Wolff A., Atkinson J. C., Macynski A. A., Fox P. C. Oral complications of cancer therapies. Pretherapy interventions to modify salivary dysfunction. NCI Monogr. 1990;(9):87–90. [PubMed] [Google Scholar]
  39. Zimmerman R. P., Mark R. J., Tran L. M., Juillard G. F. Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia. Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):571–575. doi: 10.1016/s0360-3016(96)00557-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES